T-Mobile US, Inc.
T-Mobile Announces $14.6 Billion 2026 Shareholder Return Program
Summary
On December 11, 2025, T-Mobile US, Inc. announced a new shareholder return program of up to $14.6 billion that will run through December 31, 2026. The program includes additional repurchases of shares and payment of cash dividends. The total amount available for share repurchases will be reduced by the amount of any cash dividends declared and paid by the Company. This program runs in addition to the Company's existing $14.0 billion shareholder return program announced in December 2024, which runs through December 31, 2025.
Get alerts for TMUS
Be first to know when T-Mobile US, Inc. files with the SEC.
Filing Categories
Advertisement
About T-Mobile US, Inc.
T-Mobile US, Inc. is a leading telecommunications company in the United States, recognized for its expansive 5G network and customer-first approach to wireless communication services. As a mobile carrier, T-Mobile offers a variety of services including voice, messaging, and data services to individual and business customers throughout the country. Its significant investment in cutting-edge wireless technology positions it at the forefront of innovations in connectivity and digital communications. Known for its commitment to affordable and transparent billing practices, T-Mobile challenges traditional industry norms by eliminating long-term contracts and advocating for customer-friendly policies. The company has a substantial impact on industries reliant on mobile connectivity, such as ecommerce, tech services, and IoT (Internet of Things). Headquartered in Bellevue, Washington, T-Mobile has established itself as a market disruptor, influencing competitive dynamics within the telecommunications sector by consistently focusing on network reliability, coverage, and customer satisfaction. Its contributions to the rollout and expansion of 5G infrastructure are pivotal in supporting the nation's journey towards enhanced digital transformation.
Official SEC Documents
Advertisement